EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

FGF23 in Chronic Kidney Disease: Bridging the Heart and Anemia

Andreja Figurek iD, Merita Rroji iD, Goce Spasovski

Cells · 13.02.2023 · 12 (4) · 609

DOI: 10.3390/cells12040609 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 13.02.2023. Verfasst von Andreja Figurek und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Anatomy, University of Zurich, 8057 Zurich, Switzerland. Hauptthemen laut MEDLINE: Anemia, Renal Insufficiency, Chronic, Fibroblast Growth Factor-23. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone produced mainly in osteocytes. In chronic kidney disease (CKD) FGF23 levels increase due to higher production, but also as the result of impaired cleavage and reduced excretion from the body. FGF23 has a significant role in disturbed bone and mineral metabolism in CKD, which leads to a higher cardiovascular risk and mortality in these patients. Current research has emphasized the expression of FGF23 in cardiac myocytes, fibroblasts, and endothelial cells, and in addition to the effects on the kidney, its primary role is in cardiac remodeling in CKD patients. Recent discoveries found a significant link between increased FGF23 levels and anemia development in CKD. This review describes the FGF23 role in cardiac hypertrophy and anemia in the setting of CKD and discusses the best therapeutical approach for lowering FGF23 levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnemiaRenal Insufficiency, ChronicFibroblast Growth Factor-23HumansEndothelial CellsMyocytes, Cardiac

Stichwörter der Autor:innen

anemiacardiovascular riskchronic kidney diseaseerythropoietinfibroblast growth factor 23heartiron deficiency

Substanzen

FGF23 protein, humanFibroblast Growth Factor-23

Autor:innen und Institutionen

  • Institute of Anatomy, University of Zurich, 8057 Zurich, Switzerland.
  • Department of Nephrology, Faculty of Medicine, University of Medicine Tirana, 1001 Tirana, Albania.
  • University Clinic for Nephrology, Medical Faculty, University St. Cyril and Methodius, 1000 Skopje, North Macedonia.

ORCID-Profile: Andreja Figurek, Merita Rroji

Zitieren

APA

Figurek, A., Rroji, M., & Spasovski, G. (2023). FGF23 in Chronic Kidney Disease: Bridging the Heart and Anemia. Cells, 12(4), 609. https://doi.org/10.3390/cells12040609

Vancouver

Figurek A, Rroji M, Spasovski G. FGF23 in Chronic Kidney Disease: Bridging the Heart and Anemia. Cells. 2023;12(4):609. doi:10.3390/cells12040609

BibTeX
@article{Figurek2023,
  author = {Figurek, Andreja and Rroji, Merita and Spasovski, Goce},
  title = {FGF23 in Chronic Kidney Disease: Bridging the Heart and Anemia},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {4},
  pages = {609},
  doi = {10.3390/cells12040609}
}
Kostenlos starten →